Evidence map›Paper›PMID 29788397›Full record

SynthesisClinical infectious diseases : an official publication of the Infectious Diseases Society of America2018

Polyspecific Intravenous Immunoglobulin in Clindamycin-treated Patients With Streptococcal Toxic Shock Syndrome: A Systematic Review and Meta-analysis.

Tom Parks, Clare Wilson, Nigel Curtis, Anna Norrby-Teglund, Shiranee Sriskandan

Open access · hybridAbstract readMeta-AnalysisSystematic Review
In one paragraph

Synthesis in Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 105 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
105citing papers in PubMed, 4 pooled it
12.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

105 citing papers in PubMed, 4 syntheses or guidelines pooled it, 196 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Guideline
  5. Trial
  6. Trial
  7. Review
  8. Observational
  9. Article
  10. Intravenous non-specific immunoglobulins as adjunctive therapy for invasiveRevista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia · 2026
    Observational
  11. Article
  12. Review
  13. Article
  14. Review
  15. Article
  16. Refractory septic shock: our updated pragmatic approach.Journal of anesthesia, analgesia and critical care · 2026
    Review
  17. Top unanswered questions in antimicrobial management of necrotizing soft tissue infections.Antimicrobial stewardship & healthcare epidemiology : ASHE · 2026
    Review
  18. Article
  19. Article
  20. Review

45 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 3 countries.

Tom ParksLondon School of Hygiene and Tropical Medicine, United Kingdom.
Clare WilsonImperial College London, United Kingdom.
Nigel CurtisRoyal Children's Hospital, Melbourne, Victoria, Australia.
Anna Norrby-TeglundKarolinska Institutet, Stockholm, Sweden.
Shiranee SriskandanImperial College London, United Kingdom.
Imperial College London · GBKarolinska Institutet · SELondon School of Hygiene & Tropical Medicine · GBRoyal Children's Hospital · AU

Funding

Department of Health ACF-2016-20-001Department of Health HPRU-2012-10047Medical Research Council G1100449
6 · The paper itself

Abstract

We evaluated the effect of intravenous immunoglobulin (IVIG) on mortality in clindamycin-treated streptococcal toxic shock syndrome using a meta-analysis. In association with IVIG, mortality fell from 33.7% to 15.7% with remarkable consistency across the single randomized and four nonrandomized studies.

Indexed as

ClindamycinHumansImmunoglobulins, IntravenousShock, SepticStreptococcal InfectionsStreptococcus pyogenesTreatment OutcomeClindamycinImmunoglobulins, Intravenous

Identifiers

PMID29788397
PMCPMC6186853
OpenAlexW2804222363

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.